|
Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people
|
28 July 2021 |
|
AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
|
27 July 2021 |
|
AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe
|
18 June 2021 |
|
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
|
21 May 2021 |
|
Update following statement by NIAID on AZD1222 US Phase III trial data
|
23 March 2021 |
|
AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis
|
22 March 2021 |
|
UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is safe and effective
|
18 March 2021 |
|
Agreement builds on an earlier announcement that included support for the clinical development and supply of the treatment
|
16 March 2021 |
|
Update on the safety of COVID-19 Vaccine AstraZeneca
|
14 March 2021 |
|
AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX
|
04 March 2021 |